Home

Rasă umană între timp Putere fibrogenic marker definition lucarnă Alerta Afacere

Mechanisms of fibrogenesis in liver cirrhosis: The molecular aspects of  epithelial-mesenchymal transition
Mechanisms of fibrogenesis in liver cirrhosis: The molecular aspects of epithelial-mesenchymal transition

Therapeutic pro-fibrogenic signaling pathways in fibroblasts - ScienceDirect
Therapeutic pro-fibrogenic signaling pathways in fibroblasts - ScienceDirect

Molecular and cellular mechanisms of liver fibrosis and its regression |  Nature Reviews Gastroenterology & Hepatology
Molecular and cellular mechanisms of liver fibrosis and its regression | Nature Reviews Gastroenterology & Hepatology

Initiation of hepatic stellate cell activation extends into chronic liver  disease | Cell Death & Disease
Initiation of hepatic stellate cell activation extends into chronic liver disease | Cell Death & Disease

Noninvasive measures of liver fibrosis - Rockey - 2006 - Hepatology - Wiley  Online Library
Noninvasive measures of liver fibrosis - Rockey - 2006 - Hepatology - Wiley Online Library

Mechanisms of hepatic stellate cell activation | Nature Reviews  Gastroenterology & Hepatology
Mechanisms of hepatic stellate cell activation | Nature Reviews Gastroenterology & Hepatology

Noninvasive markers of fibrosis: key concepts for improving accuracy in  daily clinical practice | Annals of Hepatology
Noninvasive markers of fibrosis: key concepts for improving accuracy in daily clinical practice | Annals of Hepatology

Frontiers | Mesenchymal Stem/Stromal Cells in Progressive Fibrogenic  Involvement and Anti-Fibrosis Therapeutic Properties
Frontiers | Mesenchymal Stem/Stromal Cells in Progressive Fibrogenic Involvement and Anti-Fibrosis Therapeutic Properties

Tissue-resident mesenchymal stromal cells: Implications for tissue-specific  antifibrotic therapies | Science Translational Medicine
Tissue-resident mesenchymal stromal cells: Implications for tissue-specific antifibrotic therapies | Science Translational Medicine

Fibrogenic Disorders in Human Diseases: From Inflammation to Organ  Dysfunction | Journal of Medicinal Chemistry
Fibrogenic Disorders in Human Diseases: From Inflammation to Organ Dysfunction | Journal of Medicinal Chemistry

Fibrogenic Potential of PW1/Peg3 Expressing Cardiac Stem Cells | Journal of  the American College of Cardiology
Fibrogenic Potential of PW1/Peg3 Expressing Cardiac Stem Cells | Journal of the American College of Cardiology

Anti-fibrogenic strategies and the regression of fibrosis - ScienceDirect
Anti-fibrogenic strategies and the regression of fibrosis - ScienceDirect

Involvement of the myeloid cell compartment in fibrogenesis and systemic  sclerosis | Nature Reviews Rheumatology
Involvement of the myeloid cell compartment in fibrogenesis and systemic sclerosis | Nature Reviews Rheumatology

Fibroblast Heterogeneity in Wound Healing: Hurdles to Clinical Translation:  Trends in Molecular Medicine
Fibroblast Heterogeneity in Wound Healing: Hurdles to Clinical Translation: Trends in Molecular Medicine

Frontiers | Liver Fibrosis in Non-alcoholic Fatty Liver Disease: From Liver  Biopsy to Non-invasive Biomarkers in Diagnosis and Treatment
Frontiers | Liver Fibrosis in Non-alcoholic Fatty Liver Disease: From Liver Biopsy to Non-invasive Biomarkers in Diagnosis and Treatment

Frontiers | Hepatic Stellate Cell-Immune Interactions in NASH
Frontiers | Hepatic Stellate Cell-Immune Interactions in NASH

Antioxidants | Free Full-Text | Hepatic Myofibroblasts: A Heterogeneous and  Redox-Modulated Cell Population in Liver Fibrogenesis
Antioxidants | Free Full-Text | Hepatic Myofibroblasts: A Heterogeneous and Redox-Modulated Cell Population in Liver Fibrogenesis

α-1 Adrenergic receptor antagonist doxazosin reverses hepatic stellate  cells activation via induction of senescence - ScienceDirect
α-1 Adrenergic receptor antagonist doxazosin reverses hepatic stellate cells activation via induction of senescence - ScienceDirect

Towards better definition, quantification and treatment of fibrosis in  heart failure. A scientific roadmap by the Committee of Translational  Research of the Heart Failure Association (HFA) of the European Society of  Cardiology -
Towards better definition, quantification and treatment of fibrosis in heart failure. A scientific roadmap by the Committee of Translational Research of the Heart Failure Association (HFA) of the European Society of Cardiology -

α-smooth muscle actin is not a marker of fibrogenic cell activity in  skeletal muscle fibrosis | PLOS ONE
α-smooth muscle actin is not a marker of fibrogenic cell activity in skeletal muscle fibrosis | PLOS ONE

PDF] Fibrogenic cell reversion underlies fibrosis regression in liver |  Semantic Scholar
PDF] Fibrogenic cell reversion underlies fibrosis regression in liver | Semantic Scholar

Hepatic fibrosis: Concept to treatment - ScienceDirect
Hepatic fibrosis: Concept to treatment - ScienceDirect

Molecular changes in fibrogenic markers (HPX, collagen, and... | Download  Scientific Diagram
Molecular changes in fibrogenic markers (HPX, collagen, and... | Download Scientific Diagram

Origin and role of hepatic myofibroblasts in hepatocellular carcinoma |  Oncotarget
Origin and role of hepatic myofibroblasts in hepatocellular carcinoma | Oncotarget

Cells | Free Full-Text | Heterogeneity of Hepatic Stellate Cells in  Fibrogenesis of the Liver: Insights from Single-Cell Transcriptomic  Analysis in Liver Injury
Cells | Free Full-Text | Heterogeneity of Hepatic Stellate Cells in Fibrogenesis of the Liver: Insights from Single-Cell Transcriptomic Analysis in Liver Injury